Direct Answer
Thermo Fisher Scientific reported revenue of $44.6 billion for the fiscal year ended December 31, 2025, with an operating margin of 17.4% and net income of $6.7 billion, according to its SEC filings. Revenue grew 3.9% from the prior year.
What Are Thermo Fisher Scientific's Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $44.6 billion | $42.9 billion | $42.9 billion | $44.9 billion |
| Operating income | $7.7 billion | $7.3 billion | $6.9 billion | $8.4 billion |
| Operating margin | 17.4% | 17.1% | 16.0% | 18.7% |
| Net income | $6.7 billion | $6.3 billion | $6.0 billion | $7.0 billion |
| Net margin | 15.1% | 14.8% | 13.9% | 15.5% |
| Operating cash flow | $7.8 billion | $8.7 billion | $8.4 billion | $9.2 billion |
| Capital expenditures | $1.5 billion | $1.4 billion | $1.5 billion | $2.2 billion |
| Free cash flow | $6.3 billion | $7.3 billion | $6.9 billion | $6.9 billion |
Operating margin held roughly steady between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $6.3 billion against net income of $6.7 billion; cash generation fell short of reported earnings, which is worth reconciling in the cash flow statement.
What Does Thermo Fisher Scientific's Balance Sheet Show?
| Cash and cash equivalents | $9.9 billion |
|---|---|
| Long-term debt | $39.2 billion |
| Total assets | $110 billion |
| Total liabilities | Not reported |
| Shareholders' equity | $53.4 billion |
| Current ratio | 1.9x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Thermo Fisher Scientific reported in its own SEC filings, read from the SEC's XBRL data (accession 0000097745-26-000018 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Thermo Fisher Scientific's revenue in fiscal 2025?
Thermo Fisher Scientific reported revenue of $44.6 billion for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Thermo Fisher Scientific's operating margin?
Thermo Fisher Scientific's operating margin was 17.4% in fiscal 2025: operating income of $7.7 billion on revenue of $44.6 billion.
How much free cash flow did Thermo Fisher Scientific generate?
Operating cash flow of $7.8 billion less capital expenditures of $1.5 billion gives free cash flow of $6.3 billion for fiscal 2025.